Skip to main content
logo
Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.780
+0.020 (1.14%)
At close: Jul 24, 2026, 4:00 PM EDT
1.740
-0.040 (-2.25%)
After-hours: Jul 24, 2026, 6:46 PM EDT

Innate Pharma Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
9.019.0120.1261.6457.6724.7
Revenue Growth
-28.67%-55.25%-67.36%6.88%133.47%-64.59%
Gross Profit
9.019.0120.1261.6457.6724.7
Operating Income
-54.01-54.01-51.58-12.67-57.43-47.83
Net Income
-49.18-49.18-49.47-7.57-58.1-52.81
Earnings Per Share
-0.55-0.55-0.61-0.09-0.73-0.66
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
34.3134.3180.7792.46101.49119.84
Total Debt
22.5722.573139.8942.2544.25
Net Cash (Debt)
11.7411.7449.7852.5659.2375.59
Net Cash Growth
-64.43%-76.42%-5.30%-11.26%-21.63%-42.98%
Net Cash Per Share
0.130.130.610.650.740.95

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-52.76-52.76-6.9-32.56-19.16-58.46
Capital Expenditures
-0.14-0.14-0.39-0.35-0.54-0.93
Free Cash Flow
-52.9-52.9-7.29-32.91-19.69-59.39
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-599.76%-599.76%-256.32%-20.55%-99.57%-193.60%
Pretax Margin
-546.11%-546.11%-245.87%-12.28%-100.52%-184.10%
Profit Margin
-546.11%-546.11%-245.87%-12.28%-100.52%-184.10%
FCF Margin
-587.40%-587.40%-36.22%-53.39%-34.14%-240.40%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
16.0615.507.133.304.8012.91